Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
85.4M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
56.8M
-
Shares change
-
-1.02M
-
Total reported value, excl. options
-
$190M
-
Value change
-
-$5.74M
-
Put/Call ratio
-
0.5
-
Number of buys
-
58
-
Number of sells
-
-62
-
Price
-
$3.35
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q1 2023
148 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q1 2023.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.8M shares
of 85.4M outstanding shares and own 66.5% of the company stock.
Largest 10 shareholders include FMR LLC (11.6M shares), BlackRock Inc. (8.04M shares), EcoR1 Capital, LLC (6.18M shares), VANGUARD GROUP INC (4.59M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), FEDERATED HERMES, INC. (2.04M shares), STATE STREET CORP (1.86M shares), CITADEL ADVISORS LLC (1.58M shares), Cormorant Asset Management, LP (1.55M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.49M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.